Literature DB >> 18437155

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.

Charles N Serhan1, Nan Chiang, Thomas E Van Dyke.   

Abstract

Active resolution of acute inflammation is a previously unrecognized interface between innate and adaptive immunity. Once thought to be a passive process, the resolution of inflammation is now shown to involve active biochemical programmes that enable inflamed tissues to return to homeostasis. This Review presents new cellular and molecular mechanisms for the resolution of inflammation, revealing key roles for eicosanoids, such as lipoxins, and recently discovered families of endogenous chemical mediators, termed resolvins and protectins. These mediators have anti-inflammatory and pro-resolution properties, thereby protecting organs from collateral damage, stimulating the clearance of inflammatory debris and promoting mucosal antimicrobial defence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437155      PMCID: PMC2744593          DOI: 10.1038/nri2294

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  112 in total

Review 1.  Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury.

Authors:  C D Collard; S Gelman
Journal:  Anesthesiology       Date:  2001-06       Impact factor: 7.892

2.  Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4).

Authors:  Iolanda M Fierro; Jeffery L Kutok; Charles N Serhan
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

3.  Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly.

Authors:  P F T Cezar-de-Mello; V Nascimento-Silva; C G Villela; I M Fierro
Journal:  Oncogene       Date:  2006-01-05       Impact factor: 9.867

4.  Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity.

Authors:  J Aliberti; S Hieny; C Reis e Sousa; C N Serhan; A Sher
Journal:  Nat Immunol       Date:  2001-12-17       Impact factor: 25.606

5.  The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering.

Authors:  Amiram Ariel; Pin-Lan Li; Wei Wang; Wang-Xian Tang; Gabrielle Fredman; Song Hong; Katherine H Gotlinger; Charles N Serhan
Journal:  J Biol Chem       Date:  2005-10-10       Impact factor: 5.157

Review 6.  Mechanisms of action of docosahexaenoic acid in the nervous system.

Authors:  N Salem; B Litman; H Y Kim; K Gawrisch
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

7.  Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function.

Authors:  D P Basile; D Donohoe; K Roethe; J L Osborn
Journal:  Am J Physiol Renal Physiol       Date:  2001-11

8.  Lipid mediator class switching during acute inflammation: signals in resolution.

Authors:  B D Levy; C B Clish; B Schmidt; K Gronert; C N Serhan
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

9.  Prostaglandins, bioassay and inflammation.

Authors:  R J Flower
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

10.  Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.

Authors:  Geraldine Canny; Ofer Levy; Glenn T Furuta; Sailaja Narravula-Alipati; Richard B Sisson; Charles N Serhan; Sean P Colgan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

View more
  1057 in total

Review 1.  Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.

Authors:  Marco Sisignano; Ralf Baron; Klaus Scholich; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2014-11-04       Impact factor: 42.937

2.  The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?

Authors:  Sesquile Ramon; Steven F Baker; Julie M Sahler; Nina Kim; Eric A Feldsott; Charles N Serhan; Luis Martínez-Sobrido; David J Topham; Richard P Phipps
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

3.  Targeted knock-down of a structurally atypical zebrafish 12S-lipoxygenase leads to severe impairment of embryonic development.

Authors:  Ulrike Haas; Elisabeth Raschperger; Mats Hamberg; Bengt Samuelsson; Karl Tryggvason; Jesper Z Haeggström
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

4.  Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation.

Authors:  Fan Zhang; Hua Yang; Zan Pan; Zheng Wang; J Mario Wolosin; Per Gjorstrup; Peter S Reinach
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

5.  A subclass of acylated anti-inflammatory mediators usurp Toll-like receptor 2 to inhibit neutrophil recruitment through peroxisome proliferator-activated receptor gamma.

Authors:  Elizabeth M Long; Alexander C Klimowicz; Heitor A Paula-Neto; Brandie Millen; Donna-Marie McCafferty; Paul Kubes; Stephen M Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 6.  Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators.

Authors:  Eric L Campbell; Charles N Serhan; Sean P Colgan
Journal:  J Immunol       Date:  2011-10-01       Impact factor: 5.422

Review 7.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

Review 8.  ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.

Authors:  Yan Gong; Zhongjie Fu; Raffael Liegl; Jing Chen; Ann Hellström; Lois Eh Smith
Journal:  Am J Clin Nutr       Date:  2017-05-17       Impact factor: 7.045

9.  Ly6C(low) monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1.

Authors:  YuFeng Peng; Yvette Latchman; Keith B Elkon
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Chronic Pancreatitis Associated Acute Respiratory Failure.

Authors:  Murli Manohar; Alok K Verma; Sathisha Upparahalli Venkateshaiah; Nathan L Sanders; Anil Mishra
Journal:  MOJ Immunol       Date:  2017-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.